
|Articles|March 5, 2013
Products in Practice 2013
Real world experience of leading ophthalmic products - issue 2
Advertisement
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
FLORetina 2025: Artificial intelligence at the frontlines of ROP care
2
FLORetina 2025: Port delivery system shows reliable 6-month durability and sustained efficacy in neovascular AMD for up to 7 years
3
How Digital Workflow Boosted my Confidence and Elevated Premium Patient Rates in Cataract Surgery
4
FLORetina 2025: Fibrosis, a limiting factor in visual acuity outcomes in neovascular AMD
5












































